AI
ADPT icon

Atom Investors’s Adaptive Biotechnologies ADPT Stock Holding History

Atom Investors’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,991
Closed -$389K – 562
2025
Q3 		$389K Buy
+25,991
New +$317K 0.03% 400
2024
Q3 		– Sell
-10,954
Closed -$39.7K – 462
2024
Q2 		$39.7K Sell
10,954
-55,010
-83% -$175K ﹤0.01% 448
2024
Q1 		$212K Buy
+65,964
New +$255K 0.03% 477
2021
Q3 		– Sell
-28,761
Closed -$1.18M – 304
2021
Q2 		$1.18M Sell
28,761
-22,140
-43% -$861K 0.24% 112
2021
Q1 		$2.05M Buy
+50,901
New +$2.76M 0.38% 66
2019
Q3 		– Sell
-20,000
Closed -$966K – 277
2019
Q2 		$966K Buy
+20,000
New +$886K 0.06% 258

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return